Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 11
2021 13
2022 9
2023 14
2024 10
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean pretto a (35 results)?
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: pretta a. Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1. Target Oncol. 2024. PMID: 38691295
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon.
Pretta A, Ziranu P, Perissinotto E, Ghelardi F, Marmorino F, Giampieri R, Puci M, De Grandis MC, Lai E, Nasca V, Ciraci P, Puzzoni M, Cerma K, Sciortino C, Taravella A, Pretta G, Giuliani L, Damonte C, Pusceddu V, Sotgiu G, Berardi R, Lonardi S, Bergamo F, Pietrantonio F, Cremolini C, Scartozzi M. Pretta A, et al. Br J Cancer. 2025 Feb;132(2):188-194. doi: 10.1038/s41416-024-02902-5. Epub 2024 Nov 27. Br J Cancer. 2025. PMID: 39604610
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Rimini M, Fornaro L, Lonardi S, Niger M, Lavacchi D, Pressiani T, Lucchetti J, Giordano G, Pretta A, Tamburini E, Pirrone C, Rapposelli IG, Diana A, Martinelli E, Garajová I, Simionato F, Schirripa M, Formica V, Vivaldi C, Caliman E, Rizzato MD, Zanuso V, Nichetti F, Angotti L, Landriscina M, Scartozzi M, Ramundo M, Pastorino A, Daniele B, Cornara N, Persano M, Gusmaroli E, Cerantola R, Salani F, Ratti F, Aldrighetti L, Cascinu S, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: pretta a. Liver Int. 2023 Aug;43(8):1803-1812. doi: 10.1111/liv.15641. Liver Int. 2023. PMID: 37452505
BRAF-mutant colorectal cancer, a different breed evolving.
Lai E, Pretta A, Impera V, Mariani S, Giampieri R, Casula L, Pusceddu V, Coni P, Fanni D, Puzzoni M, Demurtas L, Ziranu P, Faa G, Scartozzi M. Lai E, et al. Among authors: pretta a. Expert Rev Mol Diagn. 2018 Jun;18(6):499-512. doi: 10.1080/14737159.2018.1470928. Epub 2018 May 9. Expert Rev Mol Diagn. 2018. PMID: 29708446 Review.
CD44: A New Prognostic Marker in Colorectal Cancer?
Ziranu P, Pretta A, Aimola V, Cau F, Mariani S, D'Agata AP, Codipietro C, Rizzo D, Dell'Utri V, Sanna G, Moledda G, Cadoni A, Lai E, Puzzoni M, Pusceddu V, Castagnola M, Scartozzi M, Faa G. Ziranu P, et al. Among authors: pretta a. Cancers (Basel). 2024 Apr 19;16(8):1569. doi: 10.3390/cancers16081569. Cancers (Basel). 2024. PMID: 38672650 Free PMC article. Review.
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors.
Madeddu C, Gramignano G, Lai E, Pinna G, Tanca L, Cherchi MC, Floris C, Farci D, Pretta A, Scartozzi M, Macciò A. Madeddu C, et al. Among authors: pretta a. ESMO Open. 2024 Oct;9(10):103738. doi: 10.1016/j.esmoop.2024.103738. Epub 2024 Oct 10. ESMO Open. 2024. PMID: 39389003 Free PMC article. Clinical Trial.
Treatment compliance in early-stage anal cancer.
Pretta A, Trevisi E, Bregni G, Deleporte A, Hendlisz A, Sclafani F. Pretta A, et al. Ann Oncol. 2020 Oct;31(10):1282-1284. doi: 10.1016/j.annonc.2020.07.006. Epub 2020 Jul 22. Ann Oncol. 2020. PMID: 32707167 Free article. No abstract available.
BRCA-mutant pancreatic ductal adenocarcinoma.
Lai E, Ziranu P, Spanu D, Dubois M, Pretta A, Tolu S, Camera S, Liscia N, Mariani S, Persano M, Migliari M, Donisi C, Demurtas L, Pusceddu V, Puzzoni M, Scartozzi M. Lai E, et al. Among authors: pretta a. Br J Cancer. 2021 Nov;125(10):1321-1332. doi: 10.1038/s41416-021-01469-9. Epub 2021 Jul 14. Br J Cancer. 2021. PMID: 34262146 Free PMC article. Review.
Exercise Prescription in Cardio-Oncology.
Campana N, Fazzini L, Donisi C, Nava A, Migliari M, Deidda M, Pretta A, Scartozzi M, Cadeddu Dessalvi C. Campana N, et al. Among authors: pretta a. J Clin Med. 2025 May 26;14(11):3724. doi: 10.3390/jcm14113724. J Clin Med. 2025. PMID: 40507486 Free PMC article. Review.
57 results